Max Robotics — Global Service Robot Directory + US Certification

About

Sibo Tian is a radiation oncologist and clinical researcher whose work centers on the treatment of oropharyngeal squamous cell carcinoma (OPSCC), with a particular focus on optimizing surgical and radiotherapeutic strategies to improve patient outcomes while minimizing treatment-related morbidity. Tian's research has made meaningful contributions to the evolving field of transoral robotic surgery (TORS), examining how this minimally invasive approach can be integrated with — or potentially replace — conventional radiation protocols. His 2021 study, garnering 10 citations, challenged established treatment paradigms by demonstrating that intentional primary site radiation could be safely omitted following TORS in select patients, with no observed local-regional failures across 59 cases — a finding with significant implications for reducing radiation toxicity. His subsequent 2022 population-level investigation, drawing on National Cancer Database data, provided critical real-world insight into 90-day mortality rates following TORS compared to radiation at Commission on Cancer-accredited facilities, filling an important gap between controlled trial outcomes and clinical practice. Through rigorous institutional and national database analyses, Tian has positioned himself as a thoughtful contributor to evidence-based decision-making in head and neck oncology, helping clinicians better weigh surgical versus radiation-based treatment approaches for OPSCC patients.